Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression

2017/08/01 by Yingyun Gong, Yizhe Ma, Zhengqin Ye +13 · 24 citations
Chemistry · Medicine · #Chemistry #Cholesterol #Cholesterol and Lipid Metabolism #Endocrinology #Euthyroid #Hormone #Internal medicine #Kexin #LDL receptor #Lipoprotein #Lipoproteins and Cardiovascular Health #Medicine #PCSK9 #Thyroid Disorders and Treatments

paper · doi:10.1016/j.metabol.2017.07.006

openalex publication_date 2017/08/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Changes in Lipid Indices in HIV+ Cases on HAART. [europepmc]
• Proprotein convertase subtilisin/kexin type 9 and lipid metabolism. [europepmc]
• Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists. [europepmc]
• Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement. [europepmc]
• Effect of rhTSH on Lipids. [europepmc]
• HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol. [europepmc]
• The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model. [europepmc]
• Lipidomic Perturbations in Cynomolgus Monkeys are Regulated by Thyroid Stimulating Hormone. [europepmc]
• Ovariectomy Impaired Hepatic Glucose and Lipid Homeostasis and Altered the Gut Microbiota in Mice With Different Diets. [europepmc]
• Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism. [europepmc]
• Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study. [europepmc]
• Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. [europepmc]
• Insight into the Evolving Role of PCSK9. [europepmc]
• The Relationship of Circulating Proprotein Convertase Subtilisin/Kexin Type 9 With TSH and Lipid Profile in Newly Diagnosed Patients With Subclinical and Overt Hypothyroidism. [europepmc]
• Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19. [europepmc]
• Hepatic Energy Metabolism under the Local Control of the Thyroid Hormone System. [europepmc]
• The Association of Thyroid-Stimulating Hormone (TSH) Levels and Lipid Profile in Euthyroid Patients with Familial Hypercholesterolemia. [europepmc]
• Hypothyroidism increases angiotensinogen gene expression associated with vascular smooth muscle cells cholesterol metabolism dysfunction and aorta remodeling in Psammomys obesus. [europepmc]
• The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study. [europepmc]
• Maternal nutrient metabolism in the liver during pregnancy. [europepmc]
• miR-181d-5p ameliorates hypercholesterolemia by targeting PCSK9. [europepmc]
• Research status of subclinical hypothyroidism promoting the development and progression of cardiovascular diseases. [europepmc]
• Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease. [europepmc]
• Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach. [europepmc]